(Q35701281)

9 August 2017

1 reference

title

Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives (English)

1 reference

9 August 2017

hepatocellular carcinoma

1 reference

Hui-Chuan Sun

1

1 reference

PubMed ID

15034787

9 August 2017

Zhao-You Tang

series ordinal

2

1 reference

9 August 2017

18 March 2004

1 reference

Journal of Cancer Research and Clinical Oncology

9 August 2017

1 reference

9 August 2017

130

1 reference

9 August 2017

6

1 reference

9 August 2017

307-319

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-003-0530-y

9 August 2017

0 references

cites work

Role of angiogenesis in hepatitis and hepatocellular carcinoma

1 reference

12 December 2020

Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus

1 reference

12 December 2020

Angiogenesis inhibitor TNP-470: cytotoxic effects on human neoplastic cell lines

1 reference

12 December 2020

Chemoembolization with cisplatin, lipiodol and Gelfoam and subsequent systemic chemotherapy with cisplatin and interferon in patients with hepatocellular carcinoma: a non-randomized prospective study

1 reference

12 December 2020

Heparin-binding angiogenesis factors: detection by immunological methods.

1 reference

12 December 2020

Antitumor effect of TNP-470 is not associated to decrease of angiogenesis in an experimental malignant neuroectodermic tumor

1 reference

12 December 2020

Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma

1 reference

12 December 2020

Antiangiogenic therapy against experimental glioblastoma using genetically engineered cells producing interferon-alpha, angiostatin, or endostatin

1 reference

12 December 2020

Interferon-alpha delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases.

1 reference

12 December 2020

Octreotide in hepatocellular carcinoma

1 reference

12 December 2020

Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis.

1 reference

12 December 2020

Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus

1 reference

12 December 2020

Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts

1 reference

12 December 2020

Isolating vessels from the mouse brain for gene expression analysis using laser capture microdissection.

1 reference

12 December 2020

Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer.

1 reference

12 December 2020

Angiogenesis inhibitor TNP-470 augments the effect of repeated arterial ischemia on growth but does not affect take in a rat liver tumor model

1 reference

12 December 2020

Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation

1 reference

12 December 2020

The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin-8 production

1 reference

12 December 2020

Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 cases

1 reference

12 December 2020

Regulatory peptide receptors in human hepatocellular carcinomas

1 reference

12 December 2020

Cancer: looking outside the genome

1 reference

12 December 2020

KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells

1 reference

12 December 2020

Different features of angiogenesis between ovarian and breast carcinoma

1 reference

12 December 2020

Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.

1 reference

12 December 2020

Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study

1 reference

12 December 2020

Antiangiogenic effect of octreotide inhibits the growth of human rectal neuroendocrine carcinoma

1 reference

12 December 2020

Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma

1 reference

12 December 2020

Expression of genes involved in vascular development and angiogenesis in endothelial cells of adult lung.

1 reference

12 December 2020

Expression of vascular endothelial growth factor in human hepatocellular carcinoma.

1 reference

12 December 2020

Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma

1 reference

12 December 2020

The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma

1 reference

12 December 2020

Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma

1 reference

12 December 2020

Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia

1 reference

12 December 2020

Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma

1 reference

12 December 2020

Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer

1 reference

12 December 2020

Microvessel density of hepatocellular carcinoma: its relationship with prognosis

1 reference

12 December 2020

Genes expressed in human tumor endothelium

1 reference

12 December 2020

In vitro antiangiogenic effect of sandostatin (octreotide) on the proliferation of the placental vessels.

1 reference

12 December 2020

Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.

1 reference

12 December 2020

Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues

1 reference

12 December 2020

Sinusoidal capillarization of human hepatocellular carcinoma: possible promotion by fibroblast growth factor

1 reference

12 December 2020

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

1 reference

12 December 2020

Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis

1 reference

12 December 2020

Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas

1 reference

12 December 2020

Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor

1 reference

12 December 2020

TNP-470 inhibits collateralization to complement the anti-tumour effect of hepatic artery ligation

1 reference

12 December 2020

Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma.

1 reference

12 December 2020

Inflammation and cancer

1 reference

12 December 2020

Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody

1 reference

12 December 2020

Scavenger receptor block as strategy for the identification of bone marrow homing phages by panning in vivo random peptide phage displayed libraries

1 reference

12 December 2020

Angiogenesis in hepatocellular carcinoma as evaluated by alpha smooth muscle actin immunohistochemistry

1 reference

12 December 2020

Enhanced inflammatory cytokine production at ischemia/reperfusion in human liver resection

1 reference

12 December 2020

A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.

1 reference

12 December 2020

Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolization

1 reference

12 December 2020

Arterial elements and perisinusoidal cells in borderline hepatocellular nodules and small hepatocellular carcinomas

1 reference

12 December 2020

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study

1 reference

12 December 2020

Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice.

1 reference

12 December 2020

Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells

1 reference

12 December 2020

Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines

1 reference

12 December 2020

Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma

1 reference

12 December 2020

Expression of vascular endothelial growth factor in surgical specimens of hepatocellular carcinoma

1 reference

12 December 2020

Immunohistochemical studies on endothelial cell phenotype in hepatocellular carcinoma

1 reference

12 December 2020

Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?

1 reference

12 December 2020

Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team

1 reference

12 December 2020

Endothelial-directed hepatic regeneration after partial hepatectomy.

1 reference

12 December 2020

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma

1 reference

12 December 2020

Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma.

1 reference

12 December 2020

Analysis of the role of chemokines in angiogenesis.

1 reference

12 December 2020

Angiogenesis inhibitor TNP-470 during bone marrow transplant: safety in a preclinical model

1 reference

12 December 2020

Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance

1 reference

12 December 2020

Expressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines

1 reference

12 December 2020

Serum endostatin predicts tumor vascularity in hepatocellular carcinoma

1 reference

12 December 2020

Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice

1 reference

12 December 2020

Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.

1 reference

12 December 2020

Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats

1 reference

12 December 2020

Administration of optimal biological dose and schedule of interferon alpha combined with gemcitabine induces apoptosis in tumor-associated endothelial cells and reduces growth of human pancreatic carcinoma implanted orthotopically in nude mice

1 reference

12 December 2020

Microdose alpha-interferon shows clinical and antiangiogenic effect in extramedullary myeloid tumor: a case report.

1 reference

12 December 2020

The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest

1 reference

12 December 2020

Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer.

1 reference

12 December 2020

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial

1 reference

12 December 2020

Delivery of novel therapeutic agents in tumors: physiological barriers and strategies

1 reference

12 December 2020

Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications

1 reference

12 December 2020

Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen

1 reference

12 December 2020

Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma

1 reference

12 December 2020

Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study.

1 reference

12 December 2020

Injection of antiangiogenic agents into the macaque preovulatory follicle: disruption of corpus luteum development and function

1 reference

12 December 2020

New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis

1 reference

12 December 2020

Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.

1 reference

12 December 2020

Production of latent collagenase by human umbilical vein endothelial cells in response to angiogenic preparations

1 reference

12 December 2020

A pilot study of transcatheter arterial interferon embolization for patients with hepatocellular carcinoma.

1 reference

12 December 2020

Organ targeting in vivo using phage display peptide libraries

1 reference

12 December 2020

Expression patterns of cytokines and chemokines genes in human hepatoma cells.

1 reference

12 December 2020

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer

1 reference

12 December 2020

p53 accumulation in favorable-histology Wilms tumor is associated with angiogenesis and clinically aggressive disease

1 reference

12 December 2020

Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34

1 reference

12 December 2020

Sustained biochemical remission after interferon treatment may closely be related to the end of treatment biochemical response and associated with a lower incidence of hepatocarcinogenesis

1 reference

12 December 2020

Histochemical properties of vascular and sinusoidal endothelial cells in liver diseases

1 reference

12 December 2020

Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues

1 reference

12 December 2020

Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells.

1 reference

12 December 2020

Human hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis

1 reference

12 December 2020

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

1 reference

12 December 2020

Thymidine phosphorylase (platelet-derived endothelial cell growth factor), microvessel density and clinical outcome in hepatocellular carcinoma

1 reference

12 December 2020

Regulation of angiogenesis in human hepatomas: possible involvement of p53-inducible inhibitor of vascular endothelial cell proliferation

1 reference

12 December 2020

Plasma level of basic fibroblast growth factor increases with progression of chronic liver disease.

1 reference

12 December 2020

A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial

1 reference

12 December 2020

Ras regulation of vascular endothelial growth factor and angiogenesis

1 reference

12 December 2020

Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells

1 reference

12 December 2020

Tumor hepatocytes and basement membrane-Producing cells specifically express two different forms of the endostatin precursor, collagen XVIII, in human liver cancers

1 reference

12 December 2020

High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential

1 reference

12 December 2020

Clinical translation of angiogenesis inhibitors

1 reference

12 December 2020

Combined stimulation with interferon alpha and retinoic acid synergistically inhibits proliferation of the glioblastoma cell line GB12.

1 reference

12 December 2020

Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study

1 reference

12 December 2020

Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma

1 reference

12 December 2020

Isolation and characterization of murine retinal endothelial cells

1 reference

12 December 2020

Intra-arterial administration of the angiogenesis inhibitor TNP-470 blocks liver metastasis in a rabbit model

1 reference

12 December 2020

Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach

1 reference

12 December 2020

Basic fibroblast growth factor regulates proliferation and motility of human hepatoma cells by an autocrine mechanism

1 reference

12 December 2020

Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a.

1 reference

12 December 2020

Regulation of angiogenesis by hypoxia: role of the HIF system

1 reference

12 December 2020

Human tumor cells synthesize an endothelial cell growth factor that is structurally related to basic fibroblast growth factor

1 reference

12 December 2020

Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery

1 reference

12 December 2020

Consequences of angiogenesis for tumor progression, metastasis and cancer therapy.

1 reference

12 December 2020

Safety and pharmacokinetic effects of TNP-470, an angiogenesis inhibitor, combined with paclitaxel in patients with solid tumors: evidence for activity in non-small-cell lung cancer

1 reference

12 December 2020

Angiogenesis inhibitor TNP-470 prevents implanted liver metastases after partial hepatectomy in an experimental model without impairing wound healing

1 reference

12 December 2020

Somatostatin analogs inhibit neonatal retinal neovascularization

1 reference

12 December 2020

Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study

1 reference

12 December 2020

Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities.

1 reference

12 December 2020

The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification

1 reference

12 December 2020

Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma.

1 reference

12 December 2020

The role of sandostatin LAR in treating patients with advanced hepatocellular cancer.

1 reference

12 December 2020

An immunohistochemical study of the blood vessels within primary hepatocellular tumours

1 reference

12 December 2020

Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma

1 reference

12 December 2020

Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma

1 reference

12 December 2020

Enhanced CD34 expression of sinusoid-like vascular endothelial cells in hepatocellular carcinoma

1 reference

12 December 2020

Antiangiogenic treatment (TNP-470/minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma

1 reference

12 December 2020

Phenotype changes in tumor vessels associated with the progression of hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S00432-003-0530-Y

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

15034787